title: Elimination half-life may explain the relative efficacy of boceprevir and telaprevir in the treatment of hepatitis C virus genotype 1.
authors: Andrea
authors: A
authors: Calcagno
authors: Lucio
authors: L
authors: Boglione
authors: Francesco Giuseppe
authors: FG
authors: De Rosa
authors: Giovanni
authors: G
authors: Di Perri
authors: Stefano
authors: S
authors: Bonora
mesh_terms: D000998:Antiviral Agents / Q000627:therapeutic use*; D005838:Genotype; D016174:Hepacivirus / Q000235:genetics*; D006526:Hepatitis C / Q000188:drug therapy*; D006801:Humans; D009842:Oligopeptides / Q000627:therapeutic use*; D011392:Proline / Q000031:analogs & derivatives*
chemical_list: D000998:Antiviral Agents; D009842:Oligopeptides; D011392:Proline